Role of metabolism during viral infections, and crosstalk with the innate immune system

Intractable and Rare Diseases Research

Volumn 5, Issue 2, 2016, Pages 90-96

  Plaza, Juan José González ^a,b   Hulak, Nataša ^c   Kausova, Galina ^d   Zhumadilov, Zhaxybay ^e   Akilzhanova, Ainur ^e  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b Croatia   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d Kazakhstan School of Public Health   (Kazakhstan)

^e NAZARBAYEV UNIVERSITY   (Kazakhstan)

Author keywords

Innate immune system; Metabolism; Metabolomics; Viral infections; Virus

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

CITRIC ACID CYCLE; CYTOKINE RELEASE; DENDRITIC CELL; DENGUE VIRUS; EPSTEIN BARR VIRUS; FATTY ACID SYNTHESIS; GLYCOLYSIS; HANTAVIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; MACROPHAGE; METABOLISM; METABOLOMICS; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

EID: 85017596792     PISSN: 21863644     EISSN: 2186361X     Source Type: Journal    
DOI: 10.5582/irdr.2016.01008     Document Type: Review

References (75)

1. Mingeot-Leclercq M-P, Décout J-L. Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides. Med Chem Commun. 2016; DOI: 10.1039/C5MD00503E.
2. Fujino T, Nakamuta M, Yada R, et al. Expression profile of lipid metabolism-associated genes in hepatitis C virusinfected human liver. Hepatol Res. 2010; 40:923-939.
3. Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015; 479:609-618.
4. DeVito SR, Ortiz-Riaño E, Martínez-Sobrido L, Munger J. Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylation. Proc Natl Acad Sci U S A. 2014; 111:18019-18024.
5. Noto A, Dessi A, Puddu M, Mussap M, Fanos V. Metabolomics technology and their application to the study of the viral infection. J Matern Neonatal Med. 2014; 27:53-57.
6. Brunton J, Steele S, Ziehr B, Moorman N, Kawula T. Feeding uninvited guests: mTOR and AMPK set the table for intracellular pathogens. PLoS Pathog. 2013; 9:e1003552.
7. Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A. 2005; 102:2561-2566.
8. Kogovsek P, Pompe-Novak M, Petek M, Fragner L, Weckwerth W, Gruden K. Primary metabolism, phenylpropanoids and antioxidant pathways are regulated in potato as a response to potato virus Y infection. PLoS One. 2016; 11:e0146135.
9. Rosenwasser S, Mausz MA, Schatz D, Sheyn U, Malitsky S, Aharoni A, Weinstock E, Tzfadia O, Ben-Dor S, Feldmesser E, Pohnert G, Vardi A. Rewiring host lipid metabolism by large viruses determines the fate of emiliania huxleyi, a bloom-forming alga in the ocean. Plant Cell. 2014; 26:2689-2707.
10. Delgado T, Sanchez EL, Camarda R, Lagunoff M. Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection. PLoS Pathog. 2012; 8:e1002866.
11. Biswas SK, Mantovani A. Orchestration of metabolism by macrophages. Cell Metab. 2012; 15:432-437.
12. Zhu L, Zhao Q, Yang T, Ding W, Zhao Y. Cellular metabolism and macrophage functional polarization. Int Rev Immunol. 2015; 34:82-100.
13. Forterre P. Defining life: The virus viewpoint. Orig Life Evol Biosph. 2010; 40:151-160.
14. Knight B. Physiological background to microbial inhibition. Bull World Health Organ. 1952; 6:229.
15. Fontaine KA. Analysis of metabolic alterations in carbon utilization pathways during virus infection. 2014. https:// digital.lib.washington.edu/researchworks/bitstream/ handle/1773/26079/Fontaine_washington_0250E_13732. pdf?sequence=1&isAllowed=y (accessed March 25, 2016).
16. Miyake-Stoner SJ, O'Shea CC. Metabolism goes viral. Cell Metab. 2014; 19:549-550.
17. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006; 2:1165-1175.
18. Koyuncu E, Purdy JG, Rabinowitz JD, Shenk T. Saturated very long chain fatty acids are required for the production of infectious human cytomegalovirus progeny. PLoS Pathog. 2013; 9:e1003333.
19. Goodwin CM, Xu S, Munger J. Stealing the keys to the kitchen: Viral manipulation of the host cell metabolic network. Trends Microbiol. 2015; 23:789-798.
20. Fischl W, Bartenschlager R. Exploitation of cellular pathways by dengue virus. Curr OpinMicrobiol. 2011; 14:470-475.
21. Wa r b u rg O . Ve r s u c h e u n d u b e r l e d b e u d em carcinomgewebe (methoden). Biochem Z. 142:317-333.
22. Garber K. Energy boost: The warburg effect returns in a new theory of cancer. J. Natl Cancer Inst. 2004; 96:1805-1806.
23. Schönrich G, Rang A, Lütteke N, Raftery MJ, Charbonnel N, Ulrich RG. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev. 2008; 225:163-189.
24. Chang B, Crowley M, Campen M, Koster F. Hantavirus cardiopulmonary syndrome. Semin Respir CritCare Med. 2007; 28:193-200.
25. Cheng E, Wang Z, Mir MA. Interaction between hantavirus nucleocapsid protein (N) and RNA dependent RNA polymerase (RdRp) mutant reveals the requirement of N-RdRp interaction for viral RNA synthesis. J Virol. 2014; 88:8706-8712.
26. Jonsson CB, Schmaljohn CS. Replication of hantaviruses. Curr Top Microbiol Immunol. 2000; 256:15-32.
27. Munger J, Bennett BD, Parikh A, Feng X-J, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol. 2008; 26:1179-1186.
28. Kelly B, O'Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015; 25:771-784.
29. Fontaine KA, Camarda R, Lagunoff M. Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol. 2014; 88:4366-4374.
30. Schountz T, Prescott J. Hantavirus immunology of rodent reservoirs: Current status and future directions. Viruses. 2014; 6:1317-1335.
31. Kilcher S, Mercer J. Next generation approaches to study virus entry and infection. Curr Opin Virol. 2014; 4:8-14.
32. Li Y, Webster-Cyriaque J, Tomlinson CC, Yohe M, Kenney S. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. J Virol. 2004; 78:4197-4206.
33. Namazue J, Kato T, Okuno T, Shiraki K, Yamanishi K. Evidence for attachment of fatty acid to varicellazoster virus glycoproteins and effect of cerulenin on the maturation of varicella-zoster virus glycoproteins. Intervirology. 1989; 30:268-277.
34. Guinea R, Carrasco L. Phospholipid biosynthesis and poliovirus genome replication, two coupled phenomena. EMBO J. 1990; 9:2011-2016.
35. Yang W, Hood BL, Chadwick SL, Liu S, Watkins SC, Luo G, Conrads TP, Wang T. Fatty acid synthase is upregulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology. 2008; 48:1396-1403.
36. Heaton NS, Perera R, Berger KL, Khadka S, Lacount DJ, Kuhn RJ, Randall G. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc Natl Acad Sci U S A. 2010; 107:17345-17350.
37. Jonsson CB, Figueiredo LTM, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010; 23:412-441.
38. Rovnak J, Stone A, Cohrs RJ. The 13th annual meeting of the rocky mountain virology association: Current advances in virology and prion biology in the rocky mountain region. Transl Biomed. 2015; 6:1-41.
39. Emini EA, Fan HY. Immunological and pharmacological approaches to the control of retroviral infections. In: Retroviruses 78 (Coffin J, Hughes SH, Varmus HE, eds). Cold Spring Harbor Laboratory Press, NY, USA, 1997; pp. 717-722.
40. Walsh D, Mohr I. Viral subversion of the host protein synthesis machinery. Nat Rev Micro. 2011; 9:860-875.
41. Roossinck MJ. Mechanisms of plant virus evolution. Annu Rev Phytopathol. 1997; 35:191-209.
42. Sánchez EG, Quintas A, Nogal M, Castelló A, Revilla Y. African swine fever virus controls the host transcription and cellular machinery of protein synthesis. Virus Res. 2013; 173:58-75.
43. Rodrigues AF, Carrondo MJT, Alves PM, Coroadinha AS. Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells. Trends Biotechnol. 2014; 32:602-607.
44. Slupsky CM, Rankin KN, Fu H, et al. Pneumococcal Pneumonia: Potential for Diagnosis through a Urinary Metabolic Profile. J Proteome Res. 2009; 8:5550-5558.
45. Schauer N, Fernie AR. Plant metabolomics: Towards biological function and mechanism. Trends Plant Sci. 2006; 11:508-516.
46. Cheng S-C, Joosten LAB, Netea MG. The interplay between central metabolism and innate immune responses. Cytokine Growth Factor Rev. 2014; 25:707-713.
47. Tsalikis J, Croitoru DO, Philpott DJ, Girardin SE. Nutrient sensing and metabolic stress pathways in innate immunity. Cell Microbiol. 2013; 15:1632-1641.
48. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006; 124:783-801.
49. Mills C. M1 and M2 macrophages: Oracles of health and disease. Crit Rev Immunol. 2012; 32:463-488.
50. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci. 2008; 13:453-461.
51. Lovren F, Pan Y, Quan A, Szmitko PE, Singh KK, Shukla PC, Gupta M, Chan L, Al-Omran M, Teoh H. Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. Am J Physiol Circ Physiol. 2010; 299:H656-H663.
52. Roszer T, Corporation HP. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015; 2015:16-18.
53. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep. 2014; 6:13.
54. Mills E, O'Neill LAJ. Succinate: A metabolic signal in inflammation. Trends Cell Biol. 2014; 24:313-320.
55. Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013; 38:633-643.
56. Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4+ T cells and macrophages using LC-MS/MS analysis. Virology. 2011; 415:153-159.
57. Pearce EJ, Everts B. Dendritic cell metabolism. Nat Rev Immunol. 2015; 15:18-29.
58. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991; 9:271-296.
59. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 2003; 19:47-57.
60. Malinarich F, Duan K, Hamid RA, Bijin A, Lin WX, Poidinger M, Fairhurst A-M, Connolly JE. High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J Immunol. 2015; 194:5174-5186.
61. Cerwenka A, Lanier LL. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. 2016; 16:112-123.
62. Iannello A, Thompson TW, Ardolino M, Marcus A, Raulet DH. Immunosurveillance and immunotherapy of tumors by innate immune cells. Curr Opin Immunol. 2016; 38:52-58.
63. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008; 9:503-510.
64. Wolter F, Glässner A, Krämer B, Kokordelis P, Finnemann C, Kaczmarek DJ, Goeser F, Lutz P, Nischalke HD, Strassburg CP. Hypoxia impairs anti-viral activity of natural killer (NK) cells but has little effect on anti-fibrotic NK cell functions in hepatitis C virus infection. J Hepatol. 2015; 63:1334-1344.
65. Ballou LM, Lin RZ. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008; 1:27-36.
66. Viel S, Marçais A, Guimaraes FS, et al. TGF-ß inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci Signal. 2016; 9:ra19.
67. Cardaci S, Ciriolo MR. TCA cycle defects and cancer: When metabolism tunes redox state. Int J Cell Biol. 2012; 2012:161837.
68. Keppel MP, Saucier N, Mah AY, Vogel TP, Cooper MA. Activation-Specific Metabolic Requirements for NK Cell IFN-? Production. J Immunol. 2015; 194:1954-1962.
69. Lamas B, Nachat-Kappes R, Goncalves-Mendes N, Mishellany F, Rossary A, Vasson M-P, Farges M-C. Dietary fat without body weight gain increases in vivo MCF-7 human breast cancer cell growth and decreases natural killer cell cytotoxicity. Mol Carcinog. 2015; 54:58-71.
70. Viel S, Besson L, Charrier E, Marçais A, Disse E, Bienvenu J, Walzer T, Dumontet C. Alteration of natural killer cell phenotype and function in obese individuals. Clin Immunol. 2016; pii: S1521-6616(16)30006-7.
71. Chawla A, Nguyen KD, Goh YPS. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 2011; 11:738-749.
72. González-Plaza JJ, Gutiérrez-Repiso C, García-Serrano S, Rodriguez-Pacheco F, Garrido-Sánchez L, Santiago-Fernández C, García-Arnés J, Moreno-Ruiz FJ, Rodríguez-Cañete A, García-Fuentes E. Effect of Roux-en-Y gastric bypass-induced weight loss on the transcriptomic profiling of subcutaneous adipose tissue. Surg Obes Relat Dis. 2015; 12:257-263.
73. Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016; 12:15-28.
74. Fiehn O. Metabolomics -the link between genotypes and phenotypes. Plant Mol Biol. 2002; 48:155-171.
75. Rezzi S, Ramadan Z, Martin FPJ, Fay LB, Van Bladeren P, Lindon JC, Nicholson JK, Kochhar S. Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res. 2007; 6:4469-4477.